THERALASE COMMENCES SMALL ANIMAL PRE-CLINICAL TRIALS FOR DESTRUCTION OF CANCER CELLS
TORONTO, ONTARIO--(Marketwire - Nov. 9, 2010) - Theralase Technologies Inc. (TSX VENTURE:TLT) has commenced the pre-clinical trial phase of its cancer research project; evaluating its patented Photo Dynamic Compounds (PDCs) in a small animal in-vivo model. MORE >>
